A detailed history of Great West Life Assurance CO transactions in Johnson & Johnson stock. As of the latest transaction made, Great West Life Assurance CO holds 3,257,275 shares of JNJ stock, worth $528 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
3,257,275
Previous 3,069,005 6.13%
Holding current value
$528 Million
Previous $486 Million 2.03%
% of portfolio
0.9%
Previous 0.98%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $27.2 Million - $29.7 Million
188,270 Added 6.13%
3,257,275 $476 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $21.7 Million - $22.8 Million
139,800 Added 4.77%
3,069,005 $486 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $7.98 Million - $8.71 Million
54,807 Added 1.91%
2,929,205 $457 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $66.3 Million - $74.3 Million
-425,778 Reduced 12.9%
2,874,398 $448 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $21.1 Million - $22.7 Million
-136,605 Reduced 3.97%
3,300,176 $549 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $4.7 Million - $5.6 Million
-31,092 Reduced 0.9%
3,436,781 $533 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $27.8 Million - $31.2 Million
173,309 Added 5.26%
3,467,873 $616 Million
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $321,530 - $357,783
1,993 Added 0.06%
3,294,564 $538 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $554 Million - $612 Million
3,292,571 New
3,292,571 $586 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $541 Million - $598 Million
-3,217,531 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $1.98 Million - $2.25 Million
-12,507 Reduced 0.39%
3,217,531 $598 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $132 Million - $146 Million
846,178 Added 35.5%
3,230,038 $551 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $41.7 Million - $46.3 Million
-258,037 Reduced 9.77%
2,383,860 $387 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $3.91 Million - $4.19 Million
24,497 Added 0.94%
2,641,897 $435 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $53.9 Million - $60.1 Million
-352,423 Reduced 11.87%
2,617,400 $427 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $22.4 Million - $25.7 Million
163,121 Added 5.81%
2,969,823 $467 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $16.3 Million - $17.9 Million
-116,130 Reduced 3.97%
2,806,702 $418 Million
Q2 2020

Aug 17, 2020

SELL
$128.81 - $155.51 $57.9 Million - $70 Million
-449,877 Reduced 13.34%
2,922,832 $409 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $18.7 Million - $26 Million
168,673 Added 5.26%
3,372,709 $444 Million
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $106 Million - $122 Million
-833,105 Reduced 20.64%
3,204,036 $467 Million
Q3 2019

Oct 25, 2019

BUY
$126.95 - $142.14 $22.1 Million - $24.7 Million
173,747 Added 4.5%
4,037,141 $523 Million
Q2 2019

Jul 31, 2019

BUY
$131.15 - $144.24 $12.3 Million - $13.6 Million
93,984 Added 2.49%
3,863,394 $0
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $18.8 Million - $20.9 Million
149,309 Added 4.12%
3,769,410 $526 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $5.52 Million - $6.64 Million
44,902 Added 1.26%
3,620,101 $456 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $18.8 Million - $22.1 Million
-154,837 Reduced 4.15%
3,575,199 $495 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $6.46 Million - $7.13 Million
-54,080 Reduced 1.43%
3,730,036 $453 Million
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $9.03 Million - $10.7 Million
72,159 Added 1.94%
3,784,116 $485 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $21.4 Million - $23.4 Million
-163,050 Reduced 4.21%
3,711,957 $518 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $502 Million - $525 Million
3,875,007
3,875,007 $501 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.